If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMelrose Regulatory News (MRO)

Share Price Information for Melrose (MRO)

Share Price is delayed by 15 minutes
Get Live Data
502.80    4.10 (0.82%)
Bid:
503.80
Ask:
504.20
Spread: 0.40 (0.079%)
Market Cap: £6.27b
MRO Live PriceLast checked at - London Stock Exchange

Intraday Melrose Share Chart

Holding(s) in Company

5 May 2020 16:09

RNS Number : 0154M
Melrose Industries PLC
05 May 2020
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Melrose Industries plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

 

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify)iii:

 

3. Details of person subject to the notification obligationiv

Name

Aviva plc & its subsidiaries

City and country of registered office (if applicable)

London, England

4. Full name of shareholder(s) (if different from 3.)v

Name

Registered Holder:

 

Available Upon Request 12,684*

Chase (GA Group) Nominees Limited 52,885,838*

Chase Nominees Limited 455,941*

 

HSBC Global Custody Nominee (UK) Limited

91,936,013*

State Street Nominees Limited 564,180*

*denotes direct interest

 

 

City and country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reachedvi:

04/05/2020

6. Date on which issuer notified (DD/MM/YYYY):

05/05/2020

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

3.00%

 

3.00%

4,858,254,963

Position of previous notification (if

applicable)

2.99%

 

2.99%

 

        

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Ordinary SharesGB00BZ1G4322

145,854,656

Not disclosable

3.00%

Not disclosable

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. A

145,854,656

3.00%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. B 1

 

 

 

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8.B.2

 

 

 

 

          

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

 

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Aviva plc

3.00%

 

3.00%

Aviva Group Holdings Limited

3.00%

 

3.00%

Aviva Investors Holdings Limited

3.00%

 

3.00%

Aviva Investors Global Services Limited

3.00%

 

3.00%

 

 

 

 

Aviva plc

3.00%

 

3.00%

Aviva Group Holdings Limited

3.00%

 

3.00%

Friends Provident

International Limited

 

 

 

     

 

 

 

 

 

 

 

 

10. In case of proxy voting, please identify:

Name of the proxy holder

See Section 4

The number and % of voting rights held

 

The date until which the voting rights will be held

 

 

11. Additional informationxvi

This notification is prompted by a

 

 

 

Place of completion

Norwich, England

Date of completion

5 May 2020

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLEASSSEEXEEFA
Date   Source Headline
9th Apr 20217:00 amRNSAppointment of Non-Executive Directors
31st Mar 20214:30 pmRNSAnnual Financial Report
26th Mar 20215:00 pmRNSStandard annual confirmation of POUs
4th Mar 20214:04 pmRNSDirector/PDMR Shareholding
4th Mar 20217:00 amRNSFinal Results
21st Jan 20214:45 pmRNSResult of Meeting
4th Jan 20217:00 amRNSAppointment of Executive Director
29th Dec 202012:30 pmRNSPosting of Circular and Notice of General Meeting
8th Dec 20204:05 pmRNSHolding(s) in Company
25th Nov 20207:00 amRNSTrading Statement
25th Sep 20209:51 amRNSDirector/PDMR Shareholding
3rd Sep 20207:00 amRNSHalf-year Report
4th Aug 20207:00 amRNSFinancing Update
22nd Jul 20207:00 amRNSTrading Statement
4th Jun 20202:36 pmRNSDirector/PDMR Shareholding
28th May 20207:00 amRNSDirector/PDMR Shareholding
14th May 20207:00 amRNSDirector/PDMR Shareholding
7th May 202012:56 pmRNSResult of AGM
7th May 20207:00 amRNSTrading Statement
6th May 20204:56 pmRNSHolding(s) in Company - Replacement
5th May 20204:10 pmRNSHolding(s) in Company
5th May 20204:09 pmRNSHolding(s) in Company
4th May 20207:00 amRNSHolding(s) in Company
1st May 20205:05 pmRNSHolding(s) in Company
28th Apr 20205:02 pmRNSRegulatory Filing – LR.9.2.6E
15th Apr 202011:03 amRNSHolding(s) in Company
14th Apr 20207:00 amRNSHolding(s) in Company
3rd Apr 202011:04 amRNSAnnual Report and Notice of AGM
31st Mar 20209:57 amRNSStandard annual confirmation of POUs
30th Mar 20204:25 pmRNSTrading Statement
19th Mar 20209:42 amRNSHolding(s) in Company
16th Mar 20207:00 amRNSDirector/PDMR Shareholding
13th Mar 20203:33 pmRNSHolding(s) in Company
10th Mar 20209:46 amRNSDirector/PDMR Shareholding
9th Mar 202011:13 amRNSDirector/PDMR Shareholding
9th Mar 20207:00 amRNSDirector/PDMR Shareholding
5th Mar 20207:00 amRNSFinal Results
19th Nov 20197:00 amRNSTrading Statement
18th Oct 20194:30 pmRNSDirector/PDMR Shareholding
1st Oct 20197:00 amRNSAppointment of Independent Non-Executive Director
5th Sep 20197:00 amRNSHalf-year Report
14th Jun 20194:00 pmRNSDirector/PDMR Shareholding
29th May 20194:04 pmRNSDirector/PDMR Shareholding
9th May 201912:49 pmRNSResult of AGM
9th May 20197:00 amRNSTrading Statement
5th Apr 201912:55 pmRNS2018 Annual Report and Notice of AGM
3rd Apr 20191:20 pmRNSCapital Markets Day
1st Apr 20195:43 pmRNSPost-Offer Undertakings Report
18th Mar 20194:41 pmRNSDirector/PDMR Shareholding
11th Mar 20195:01 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.